China Mengniu Dairy Company (2319) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
25 Sep, 2026Executive summary
Revenue for H1 2026 rose 7.8% year-over-year to RMB44.8 billion, driven by product innovation, omni-channel expansion, and brand initiatives.
Net profit attributable to owners increased 15.9% year-over-year to RMB2.37 billion, with EPS up 17.0%.
All major business segments achieved growth, with liquid milk leading the industry and fresh milk, cheese, and milk formula businesses each growing over 30% year-over-year.
Major sporting events (Winter Olympics, FIFA World Cup) provided significant marketing opportunities, boosting brand momentum and sales.
Management upgrades, R&D innovation, and digital transformation supported operational efficiency and product development.
Financial highlights
Gross profit increased 5.2% year-over-year to RMB18.26 billion; gross margin was 40.8%, down 0.9 percentage points year-over-year due to price adjustments and higher raw material costs.
Operating profit rose 3.9% to RMB3.68 billion; operating margin was 8.2%, down 0.3 percentage points.
EBITDA grew 12.0% to RMB5.15 billion; EBITDA margin improved to 11.5%.
Net cash inflow from operating activities was RMB2.49 billion, down 11.1% year-over-year due to higher income tax expense.
Capital expenditure decreased 51.2% year-over-year to RMB492.8 million.
Outlook and guidance
Management expects stable macroeconomic and consumer trends in H2 2026, with easing price competition and continued policy support.
Focus remains on multi-category growth, product innovation, digital transformation, and channel upgrades.
Strategic execution of the "One Core, Two Wings" strategy will continue, emphasizing brand leadership, R&D, and operational efficiency.
Ongoing commitment to stable dividend payout and share buybacks through 2027.
Plans to deepen transition to an integrated nutrition and health solutions provider.
Latest events from China Mengniu Dairy Company
- Net profit soared 1,378.9% as margins and cash flow hit records despite a 7.3% revenue drop.2319
H2 2025 - Revenue fell 6.9% but margins improved; net profit dropped 16.4% on associate losses.2319
H1 2025 - Revenue and profit declined, but margins improved and a major share buyback was announced.2319
H1 2024 - Revenue fell 10.1% as net profit plunged on impairments, but margins and dividends rose.2319
H2 2024